{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-021715","form_type":"8-K","ticker":"SMTI","cik":"0000714256","company_name":"Sanara MedTech Inc.","filed_at":"2025-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.969491+00:00","generated_at":"2026-05-16T21:55:52.256724+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Sanara MedTech Q3 revenue +22% to $26.3M; net income from continuing ops positive; THP discontinued","bullets":["Q3 net revenue $26.3M (+22% YoY); net income from continuing ops $0.8M vs loss $0.2M; Adj. EBITDA $4.9M (+$2.3M).","Soft tissue repair revenue +24% driven by CellerateRX and BIASURGE; gross margin improved to 93% from 91%.","Operations of Tissue Health Plus (THP) ceased in Q3; $26.5M noncash impairment charge; THP classified as discontinued ops.","Net loss from discontinued ops $31.2M in Q3; overall net loss $30.4M vs $2.9M loss YoY from continuing and disc ops.","Seth Yon appointed CEO effective Sept 15, 2025; Ron Nixon remains Executive Chairman."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-021715","json":"https://secwatch.observer/filing/0001493152-25-021715.json","markdown":"https://secwatch.observer/filing/0001493152-25-021715.md","text":"https://secwatch.observer/filing/0001493152-25-021715.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/714256/000149315225021715/0001493152-25-021715-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/714256/000149315225021715/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T21:55:52.256724+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}